The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

Abby Jones' first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. "Come in!" yelled Kier. Jones didn't have to knock. Kier had the screen door open and was ...

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

Strawberry Hills Pharmacy owner Daniel Jones reacted Thursday to a recent Federal Trade Commission report which showed ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...